September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response…
SALT LAKE CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing…
WuXia293Stable platform demonstrates high titer, human glycosylation and improved product quality by eliminating or significantly alleviating truncation in difficult-to-express molecules.WuXia293Stable platform maintains…
BENGALURU, India, July 17, 2025 /PRNewswire/ -- India is witnessing an alarming public health crisis with heart attacks increasingly striking…
SAN FRANCISCO--(BUSINESS WIRE)--New data from the 2025 Vagaro Vantage Report reveals higher levels of stress and other mental health concerns…
XOANACYL is an oral therapy designed to address critical challenges in CKD, including Iron deficiency and hyperphosphatemia Averoa submitted XOANACYL…
Denver, CO, June 02, 2025 (GLOBE NEWSWIRE) -- As caregiver burnout reaches unprecedented levels across the United States, a new…
RS15 Avaglide is a women’s specific boot, built to support the performance requirements of athletes in modern day rugbyThe design…
Image by PAIRMiner STUTTGART, Germany, May 31, 2025 (GLOBE NEWSWIRE) -- As Bitcoin prices rise past key resistance levels, investor…